White Paper: The Cost of Quality in the Specialty Pharmaceutical Supply Chain

By Ruediger Lomb

Quality vs Expenditure: Are you willing to risk it all? 

As R&D focus shifts towards high-precision, low-volume therapies comprising of expensive and sensitive shipments, what are the repercussions of a temperature excursion or delayed delivery? The impact can be broad and far-reaching, resulting in compounded inefficiencies and increased costs throughout the entire pharmaceutical chain, ultimately affecting the patient relying on timely treatment.

Discover how to create a new quality mindset which enables not only a more robust management system, but can add value for your organization and generate better patient outcomes. 

To download your copy, please enter your details in the form below 

 
Topics:
Quality

About the Author

Ruediger Lomb

Vice President, Enterprise Quality Assurance, International Operations
AmerisourceBergen Global Commercialization Services & Animal Health
View Bio